1. Home
  2. XRTX vs AMIX Comparison

XRTX vs AMIX Comparison

Compare XRTX & AMIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XRTX
  • AMIX
  • Stock Information
  • Founded
  • XRTX 2011
  • AMIX 2014
  • Country
  • XRTX Canada
  • AMIX United States
  • Employees
  • XRTX N/A
  • AMIX N/A
  • Industry
  • XRTX Pharmaceuticals and Biotechnology
  • AMIX
  • Sector
  • XRTX Health Care
  • AMIX
  • Exchange
  • XRTX Nasdaq
  • AMIX NYSE
  • Market Cap
  • XRTX 4.2M
  • AMIX 3.5M
  • IPO Year
  • XRTX N/A
  • AMIX N/A
  • Fundamental
  • Price
  • XRTX $0.89
  • AMIX $1.50
  • Analyst Decision
  • XRTX
  • AMIX Strong Buy
  • Analyst Count
  • XRTX 0
  • AMIX 1
  • Target Price
  • XRTX N/A
  • AMIX $5.00
  • AVG Volume (30 Days)
  • XRTX 32.6K
  • AMIX 2.6M
  • Earning Date
  • XRTX 08-13-2025
  • AMIX 08-12-2025
  • Dividend Yield
  • XRTX N/A
  • AMIX N/A
  • EPS Growth
  • XRTX N/A
  • AMIX N/A
  • EPS
  • XRTX N/A
  • AMIX N/A
  • Revenue
  • XRTX N/A
  • AMIX N/A
  • Revenue This Year
  • XRTX N/A
  • AMIX N/A
  • Revenue Next Year
  • XRTX N/A
  • AMIX N/A
  • P/E Ratio
  • XRTX N/A
  • AMIX N/A
  • Revenue Growth
  • XRTX N/A
  • AMIX N/A
  • 52 Week Low
  • XRTX $0.80
  • AMIX $1.14
  • 52 Week High
  • XRTX $2.98
  • AMIX $42.40
  • Technical
  • Relative Strength Index (RSI)
  • XRTX 54.28
  • AMIX 46.52
  • Support Level
  • XRTX $0.80
  • AMIX $1.23
  • Resistance Level
  • XRTX $0.98
  • AMIX $2.43
  • Average True Range (ATR)
  • XRTX 0.05
  • AMIX 0.18
  • MACD
  • XRTX 0.01
  • AMIX 0.04
  • Stochastic Oscillator
  • XRTX 77.53
  • AMIX 18.60

About XRTX XORTX Therapeutics Inc.

XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.

About AMIX AUTONOMIX MEDICAL INC

Autonomix Medical Inc is a development-stage medical device development company focused on advancing technologies for sensing and treating disorders relating to the nervous system. Its first-in-class technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies.

Share on Social Networks: